Identification of Psychosocial Factors Associated With Diagnostic Delay in Advanced Basal Cell Carcinoma
PSYCHO-CBC
1 other identifier
interventional
29
1 country
1
Brief Summary
The aim of this study was to identify psycho-social factors associated with diagnostic delay in advanced basal cell carcinomas. Thus, the objective is to develop recommendations to better identify CBCa populations at risk, improve earlier their diagnosis and thus their care with an adequate and targeted information.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 12, 2018
CompletedFirst Submitted
Initial submission to the registry
October 10, 2019
CompletedFirst Posted
Study publicly available on registry
October 11, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 12, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
November 12, 2019
CompletedMarch 25, 2020
March 1, 2020
1 year
October 10, 2019
March 24, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Proportion of "psycho-social factors" that chair the decision-making to consul
semi-structured interviews of patients by the psychologist
Day 1
Study Arms (2)
target subjects
EXPERIMENTAL"target subjects" patients are expected, corresponding to the average population received each year for a CBCa in the unit.
health care team
ACTIVE COMPARATORthe health care team managing these patients
Interventions
Based on an interview grid previously built, the interviews will investigate the factors governing the decision to consult and methods of intervention to reduce the time to consult.
Eligibility Criteria
You may qualify if:
- Patients over 18 years of age with a CBCa supported for less than 12 months in the onco-Dermatology unit of the CHU de Bordeaux.
- Are defined as locally advanced,tumors with major invasion of adjacent structures, that are not accessible for surgical resection or radiotherapy, .
- Patients will sign a consent after reading the fact sheet explaining the objectives of the study.
You may not qualify if:
- subjects with severe dementia (mini mental state less than 10)
- An anonymized list of non-included according to this criterion will be carried out in order to quantify the number of advanced CBC with severe dementia and also the number of refusals.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Service de Dermatologie - Hôpital Saint André
Bordeaux, 33000, France
Related Publications (1)
Garrouteigt C, Broc G, Legrand A, Quintard B, Beylot-Barry M. Facilitators of and obstacles to consultation in patients with advanced basal cell carcinoma: a French pilot study. Arch Dermatol Res. 2021 Dec;313(10):829-835. doi: 10.1007/s00403-020-02175-x. Epub 2021 Jan 12.
PMID: 33433714DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Marie BEYLOT BARRY, MD, PhD
University Hospital, Bordeaux
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 10, 2019
First Posted
October 11, 2019
Study Start
November 12, 2018
Primary Completion
November 12, 2019
Study Completion
November 12, 2019
Last Updated
March 25, 2020
Record last verified: 2020-03
Data Sharing
- IPD Sharing
- Will not share